Working... Menu

The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00044148
Recruitment Status : Completed
First Posted : August 21, 2002
Last Update Posted : February 1, 2017
Information provided by (Responsible Party):
Chromaderm, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 28, 2004
  Actual Study Completion Date : April 28, 2004